Spin-flop transition in uniaxial antiferromagnets: magnetic phases, reorientation effects, multidomain states

The classical spin-flop is the field-driven first-order reorientation transition in easy-axis antiferromagnets. A comprehensive phenomenological theory of easy-axis antiferromagnets displaying spin-flops is developed. It is shown how the hierarchy of magnetic coupling strengths in these antiferromagnets causes a strongly pronounced two-scale character in their magnetic phase structure. In contrast to the major part of the magnetic phase diagram, these antiferromagnets near the spin-flop region are described by an effective model akin to uniaxial ferromagnets. For a consistent theoretical description both higher-order anisotropy contributions and dipolar stray-fields have to be taken into account near the spin-flop. In particular, thermodynamically stable multidomain states exist in the spin-flop region, owing to the phase coexistence at this first-order transition. For this region, equilibrium spin-configurations and parameters of the multidomain states are derived as functions of the external magnetic field. The components of the magnetic susceptibility tensor are calculated for homogeneous and multidomain states in the vicinity of the spin-flop. The remarkable anomalies in these measurable quantities provide an efficient method to investigate magnetic states and to determine materials parameters in bulk and confined antiferromagnets, as well as in nanoscale synthetic antiferromagnets. The method is demonstrated for experimental data on the magnetic properties near the spin-flop region in the orthorhombic layered antiferromagnet (C_2H_5NH_3)_2CuCl_4.Comment: (15 pages, 12 figures; 2nd version: improved notation and figures, correction of various typos

Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project.

Purpose: To achieve clinical validation of cutoff values for newborn screening by tandem mass 215 spectrometry through a worldwide collaboration. Methods: Cumulative percentiles of amino 216 acids and acylcarnitines in dried blood spots of approximately 30 million normal newborns and 217 10,615 true positive cases are compared to assign clinical significance, which is achieved when 218 the median of a disease range is either >99%ile or <1%ile of the normal population. The cutoff 219 target ranges of analytes and ratios are then defined as the interval between the limits of the two 220 populations. When overlaps occur, adjustments are made to maximize sensitivity and specificity 221 taking in consideration all available factors. Results: As of December 1, 2010, 129 sites in 45 222 countries have uploaded to the project website a total of 23,970 percentile data points, 558,168 223 analyte results of 10,615 true positive cases with 64 conditions, and 5,088 cutoff values. The 224 average rate of submission of true positive cases between December 1, 2008 and December 1, 225 2010 was 4.7 cases per day (3,418 cases). This cumulative evidence generated 91 and 23 high 226 and low target cutoff ranges, respectively. The overall proportion of cutoff values within the 227 respective target range was 43% (2,176/5,088). Conclusions: An unprecedented level of 228 cooperation and collaboration has allowed the objective definition of cutoff target ranges for 114 229 markers applied to newborn screening of rare metabolic disorders. This set of data could be used 230 as baseline for monitoring of future performance

Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project

PURPOSE:: To achieve clinical validation of cutoff values for newborn screening by tandem mass spectrometry through a worldwide collaborative effort. METHODS:: Cumulative percentiles of amino acids and acylcarnitines in dried blood spots of approximately 25-30 million normal newborns and 10,742 deidentified true positive cases are compared to assign clinical significance, which is achieved when the median of a disorder range is, and usually markedly outside, either the 99th or the 1st percentile of the normal population. The cutoff target ranges of analytes and ratios are then defined as the interval between selected percentiles of the two populations. When overlaps occur, adjustments are made to maximize sensitivity and specificity taking all available factors into consideration. RESULTS:: As of December 1, 2010, 130 sites in 45 countries have uploaded a total of 25,114 percentile data points, 565,232 analyte results of true positive cases with 64 conditions, and 5,341 cutoff values. The average rate of submission of true positive cases between December 1, 2008, and December 1, 2010, was 5.1 cases/day. This cumulative evidence generated 91 high and 23 low cutoff target ranges. The overall proportion of cutoff values within the respective target range was 42% (2,269/5,341). CONCLUSION:: An unprecedented level of cooperation and collaboration has allowed the objective definition of cutoff target ranges for 114 markers to be applied to newborn screening of rare metabolic disorders. © 2011 Lippincott Williams &amp; Wilkins